Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability and efficacy of desvenlafaxine succinate
sustained release (DVS SR) in subjects with major depressive disorder.